Rhinox 0.5 mg/ ml Norge - norsk - Statens legemiddelverk

rhinox 0.5 mg/ ml

orifarm healthcare a/s - oksymetazolinhydroklorid - nesespray, oppløsning - 0.5 mg/ ml

Somac 40 mg Norge - norsk - Statens legemiddelverk

somac 40 mg

takeda as - pantoprazolnatriumsesquihydrat - pulver til injeksjonsvæske, oppløsning - 40 mg

Zycomb 0.5 mg/ ml / 0.6 mg/ ml Norge - norsk - Statens legemiddelverk

zycomb 0.5 mg/ ml / 0.6 mg/ ml

orifarm healthcare a/s - xylometazolinhydroklorid / ipratropiumbromid - nesespray, oppløsning - 0.5 mg/ ml / 0.6 mg/ ml

Zymelin 1 mg/ ml Norge - norsk - Statens legemiddelverk

zymelin 1 mg/ ml

orifarm healthcare a/s - xylometazolinhydroklorid - nesespray, oppløsning - 1 mg/ ml

Zymelin 0.5 mg/ ml Norge - norsk - Statens legemiddelverk

zymelin 0.5 mg/ ml

orifarm healthcare a/s - xylometazolinhydroklorid - nesespray, oppløsning - 0.5 mg/ ml

Tecovirimat SIGA Den europeiske union - norsk - EMA (European Medicines Agency)

tecovirimat siga

siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - antivirale midler til systemisk bruk - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 og 5. tecovirimat siga should be used in accordance with official recommendations.

Qdenga Den europeiske union - norsk - EMA (European Medicines Agency)

qdenga

takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - dengue - vaksiner - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.

Bettamousse 1 mg/ g Norge - norsk - Statens legemiddelverk

bettamousse 1 mg/ g

rph pharmaceuticals ab - betametasonvalerat - skum - 1 mg/ g

Febuxostat Mylan Den europeiske union - norsk - EMA (European Medicines Agency)

febuxostat mylan

mylan pharmaceuticals limited - febuxostat - hyperuricemia; arthritis, gouty; gout - antigout preparater - febuxostat mylan er indisert for forebygging og behandling av hyperurikemi hos voksne pasienter som gjennomgår kjemoterapi for hematologiske maligniteter ved middels risiko for tumor lysis syndrome (tls). febuxostat mylan er indisert for behandling av kronisk hyperuricaemia i situasjoner der urat deponering allerede har skjedd (inkludert en historie, eller tilstedeværelse av, tophus og/eller urinsyregikt). febuxostat mylan er indisert hos voksne.

Teveten 600 mg Norge - norsk - Statens legemiddelverk

teveten 600 mg

viatris as - eprosartanmesilat - tablett, filmdrasjert - 600 mg